| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan & TVRs | - | RNS | ||
| Fr | Diaceutics PLC - Notice of AGM & Posting of Annual Report | - | RNS | ||
| 26.05. | Diaceutics says order book and pipeline provides confidence for 2026 | 1 | Alliance News | ||
| 26.05. | Diaceutics PLC - Final Results | - | RNS | ||
| 13.05. | Diaceutics PLC - Notice of Results | - | RNS | ||
| 12.05. | Diaceutics PLC - Holding(s) in Company | - | RNS | ||
| DIACEUTICS Aktie jetzt für 0€ handeln | |||||
| 05.05. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan and TVRs | - | RNS | ||
| 16.04. | Diaceutics extends Belfast headquarters lease to 2036 | 1 | Investing.com | ||
| 16.04. | Diaceutics PLC - Related Party Transaction - Lease Extension | 1 | RNS | ||
| 01.04. | Diaceutics PLC - PDMR Shareholding/SIP & Total Voting Rights | - | RNS | ||
| 03.03. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan and TVRs | - | RNS | ||
| 03.02. | Diaceutics PLC - PDMR Shareholding/Share Incentive Plan & TVR | - | RNS | ||
| 15.01. | Diaceutics PLC - Full Year 2025 Trading Update | - | RNS | ||
| 23.12.25 | Diaceutics PLC - PDMR Shareholding/SIP & Total Voting Rights | - | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 4,240 | -2,30 % | Atossa presents preclinical data on breast cancer drug at ASCO | ||
| SENSEONICS | 5,800 | -1,69 % | Senseonics Holdings, Inc.: Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026 | ||
| VYOME | 2,320 | -0,85 % | Vyome Holdings, Inc. reports Q1 results | ||
| INTELLIGENT BIO SOLUTIONS | 2,540 | 0,00 % | Intelligent Bio Solutions starts FDA study for fingerprint drug test | ||
| PAVMED | 5,070 | -0,98 % | PAVmed Inc.: PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results | Veris Health progressed commercial expansion and advanced implantable physiological monitor development toward FDA submission
Lucid Diagnostics continued building... ► Artikel lesen | |
| FRESENIUS | 36,450 | +2,82 % | dpa-AFX-Überblick: UNTERNEHMEN vom 26.05.2026 - 15.15 Uhr | Schwerwiegende Bedenken: BP trennt sich von Verwaltungsratschef - Kursrutsch LONDON - Der britische Ölkonzern BP setzt seinen Verwaltungsratschef Albert Manifold wegen Vorwürfen vor die Tür. Als... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 35,690 | -1,95 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG beschließt Aktienrückkaufprogramm mit einem Gesamtvolumen von rund EUR 1 Milliarde in Tranchen | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Kapitalmaßnahmen / Aktienrückkäufe
Fresenius Medical Care AG: Fresenius Medical Care AG beschließt Aktienrückkaufprogramm mit... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 59,34 | -1,07 % | Morgan Stanley raises BrightSpring Health price target on valuation | ||
| ALIGNMENT HEALTHCARE | 13,640 | 0,00 % | Alignment Healthcare Shows How Earlier, Coordinated Care Leads to Better Health and Fewer Emergencies in 2025 Impact Report | ||
| SIEMENS HEALTHINEERS | 34,040 | -0,64 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. a) der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung (EU)... ► Artikel lesen | |
| BLUEJAY DIAGNOSTICS | 4,310 | 0,00 % | Morning Market Movers: Bluejay Diagnostics, Decent Holding, Abits Group, Sunshine Biopharma See Big Swings | WASHINGTON (dpa-AFX) - At 7:35 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 26,760 | -3,95 % | Procept Biorobotics wins expanded FDA IDE for Aquablation, completes study enrollment | ||
| PROGYNY | 25,115 | -4,14 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| GENEDX | 53,07 | +2,08 % | GeneDx (WGS) Fell Despite Continued Execution Improvement | ||
| BILLIONTOONE | 94,01 | -5,03 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen |